Similar articles

• Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.

  Allegra CJ, Chabner BA, Tuazon CU, Ogata-Arakaki D, Baird B, Drake JC, Simmons JT, Lack EE, Shelhamer JH, Balis F, et al. Allegra CJ, et al. N Engl J Med. 1987 Oct 15;317(16):978-85. doi: 10.1056/NEJM198710153171602. N Engl J Med. 1987. PMID: 2958710
• Pneumocystis carinii pneumonitis.

  Hughes WT. Hughes WT. N Engl J Med. 1987 Oct 15;317(16):1021-3. doi: 10.1056/NEJM198710153171608. N Engl J Med. 1987. PMID: 2958709 No abstract available.
• Trimetrexate-leucovorin dosage evaluation study for treatment of Pneumocystis carinii pneumonia.

  Sattler FR, Allegra CJ, Verdegem TD, Akil B, Tuazon CU, Hughlett C, Ogata-Arakaki D, Feinberg J, Shelhamer J, Lane HC, et al. Sattler FR, et al. J Infect Dis. 1990 Jan;161(1):91-6. doi: 10.1093/infdis/161.1.91. J Infect Dis. 1990. PMID: 2136905
• Recent developments in the therapy and management of Pneumocystis carinii pneumonia in patients with AIDS.

  Montgomery AB. Montgomery AB. AIDS Clin Rev. 1989:109-24. AIDS Clin Rev. 1989. PMID: 2535121 Review. No abstract available.
• Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia.

  Davey RT Jr, Masur H. Davey RT Jr, et al. Antimicrob Agents Chemother. 1990 Apr;34(4):499-504. doi: 10.1128/AAC.34.4.499. Antimicrob Agents Chemother. 1990. PMID: 2140495 Free PMC article. Review.